Corcept Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:CORT Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
22 Nov 24	SellUS$80,032	Joseph Lyon	Individual	1,411	US$56.72
22 Nov 24	SellUS$146,626	Gary Robb	Individual	2,609	US$56.20
26 Aug 24	SellUS$110,737	Gary Robb	Individual	3,101	US$35.71

Insider Trading Volume

Insider Buying: CORT insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of CORT?
Owner Type	Number of Shares	Ownership Percentage
State or Government	43,782	0.0418%
General Public	3,765,180	3.59%
Hedge Funds	6,509,002	6.21%
Individual Insiders	12,152,389	11.6%
Institutions	82,304,784	78.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 76.7% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
15.3%	BlackRock, Inc.	16,050,402	US$842.2m	-2.96%	0.01%
9.55%	The Vanguard Group, Inc.	10,006,330	US$525.0m	4.74%	0.01%
7.89%	Ingalls & Snyder, LLC	8,266,756	US$433.8m	0.35%	15.87%
6.21%	Renaissance Technologies LLC	6,509,002	US$341.5m	-5.84%	0.5%
5.07%	George Baker	5,310,196	US$278.6m	0%	no data
3.64%	Parallel Advisors, LLC	3,813,724	US$200.1m	-0.05%	4.56%
3.36%	State Street Global Advisors, Inc.	3,519,263	US$184.7m	0.57%	0.01%
2.88%	Joseph Belanoff	3,022,335	US$158.6m	6.72%	no data
2.42%	Dimensional Fund Advisors LP	2,532,499	US$132.9m	-5.37%	0.02%
2.3%	Novo Holdings A/S	2,411,362	US$126.5m	0%	0.1%
2.27%	Geode Capital Management, LLC	2,378,758	US$124.8m	4.36%	0.01%
2.11%	James Wilson	2,215,093	US$116.2m	0%	no data
1.51%	Arrowstreet Capital, Limited Partnership	1,580,621	US$82.9m	6.55%	0.06%
1.44%	Boston Trust Walden Company	1,513,975	US$79.4m	-4.41%	0.55%
1.3%	FMR LLC	1,363,342	US$71.5m	24.6%	no data
1.26%	First Trust Advisors LP	1,318,137	US$69.2m	-13.4%	0.06%
1.25%	David Mahoney	1,314,373	US$69.0m	0%	no data
1.17%	Jacobs Levy Equity Management Inc	1,223,781	US$64.2m	40.5%	0.24%
0.98%	Charles Schwab Investment Management, Inc.	1,026,487	US$53.9m	5.47%	0.01%
0.88%	Morgan Stanley, Investment Banking and Brokerage Investments	925,584	US$48.6m	14.5%	0.01%
0.88%	Northern Trust Global Investments	921,387	US$48.3m	-1.16%	0.01%
0.82%	Connor, Clark & Lunn Investment Management Ltd.	859,563	US$45.1m	20%	0.21%
0.78%	Norges Bank Investment Management	822,123	US$43.1m	0%	no data
0.75%	D. E. Shaw & Co., L.P.	788,064	US$41.3m	-17%	0.06%
0.64%	Invesco Capital Management LLC	672,389	US$35.3m	25.2%	0.01%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/30 06:20
End of Day Share Price	2024/12/30 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Corcept Therapeutics Incorporated is covered by 23 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Tazeen Ahmad	BofA Global Research
David Buck	B. Riley Securities, Inc.
Edward Nash	Canaccord Genuity